TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.

Richard S Finn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.